Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Other Non Operating Income (2022 - 2025)

bioAffinity Technologies has reported Other Non Operating Income over the past 4 years, most recently at $1922.0 for Q4 2025.

  • Quarterly Other Non Operating Income rose 200.31% to $1922.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40490.0 through Dec 2025, up 172.95% year-over-year, with the annual reading at $40490.0 for FY2025, 292.23% up from the prior year.
  • Other Non Operating Income was $1922.0 for Q4 2025 at bioAffinity Technologies, up from $513.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $212258.0 in Q2 2022 and troughed at -$1281.0 in Q4 2023.
  • The 4-year median for Other Non Operating Income is $1922.0 (2025), against an average of $24627.9.
  • The largest YoY upside for Other Non Operating Income was 3805200.0% in 2025 against a maximum downside of 99.96% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $212258.0 in 2022, then crashed by 100.6% to -$1281.0 in 2023, then skyrocketed by 149.96% to $640.0 in 2024, then soared by 200.31% to $1922.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Other Non Operating Income are $1922.0 (Q4 2025), $513.0 (Q3 2025), and $38053.0 (Q2 2025).